Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients

With diminishing returns and high clinical failure rates from traditional preclinical and animal-based drug discovery strategies, more emphasis is being placed on alternative drug discovery platforms. Ex vivo approaches represent a departure from both more traditional preclinical animal-based models...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagg, Hannah, Williams, Sophie T., Conroy, Samantha, Myers, Katie N., McGarrity-Cottrell, Connor, Jones, Callum, Helleday, Thomas, Rantala, Juha, Rominiyi, Ola, Danson, Sarah J., Collis, Spencer J., Wells, Greg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2023
Materias:
Method Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548111/
https://www.ncbi.nlm.nih.gov/pubmed/37799492
http://dx.doi.org/10.12688/f1000research.135809.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548111/
https://www.ncbi.nlm.nih.gov/pubmed/37799492
http://dx.doi.org/10.12688/f1000research.135809.1

Ejemplares similares